-
Mashup Score: 8
177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC (EVOLUTION) – Full Text View.
Source: clinicaltrials.govCategories: Latest Headlines, Oncologists1Tweet
177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC (EVOLUTION) – Full Text View.
A/Prof Shahneen Sandhu, PI of @ANZUPtrials #EVOLUTION #ProstateCancer ph2 #ClinicalTrial Lu-177 PSMA with ipi/nivo vs LuPSMA alone, leading the investigator meeting today to launch the trial. @TrialsCentre @PCFA @ANSTO @bmsnews @adacap_news #ARTNET #pcsm https://t.co/ympQGPHKnl https://t.co/Pci5GZEWVH